Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Tillman Pearce, MD
Threshold Pharmaceuticals
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
80 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Na Bulovce, Department of Pneumology and Thoracic Surgery
Libeň, Czechia
- General Univesity Hospital in Prague, Clinic of Oncology
Prague, Czechia
- Thomayer Hospital, Clinic of Pneumology
Prague, Czechia
- Regional Hospital T. Bta, Department of Pneumology
Zlín, Czechia
- Asklepios Fachkliniken Munchen-Gaunting
Gauting, Bavaria, Germany
- Marien Hospital Herne
Herne, North Rhine-Westphalia, Germany
- Charité Universitätsmedizin Berlin;
Berlin, Germany
- Klinikum Frankfurt Höchst Gmbh
Frankfurt, Germany
- Lungen Clinic Grosshandsdorf Gmbh
Großhansdorf, Germany
- Universitatsklinikum Schleswig-Holstein
Lübeck, Germany
- Städtisches Klinikum München - Klinikum Bogenhausen
München, Germany
- Universitätsklinikum Ulm; Zentrum Für Innere Medizin
Ulm, Germany
- Attikon University General Hospital
Athens, Greece
- Iaso General, Oncology Unit
Athens, Greece
- Department of Medical Oncology
Heraklion, Greece
- University General Hospital of Patras, Oncology Unit
Pátrai, Greece
- Koranyi National Institute of Tbc and Pulmonology, 14th Dept of Pulmonology
Budapest, Hungary
- Koranyi National Institute of Tbc and Pulmonology, 6th Department of Pulmonology
Budapest, Hungary
- Koranyi National Institute of Tbc and Pulmonology, 8th Department of Pulmonology
Budapest, Hungary
- University of Debrecen, Medical and Health Science Center, Department of Pulmonology
Debrecen, Hungary
- Csongrad County Hospital of Chest Diseases
Deszk, Hungary
- Hetenyi Geza Hospital, Department of Oncology
Szolnok, Hungary
- "mater Salutis" Hospital - Operative Unit of Oncology
Verona, Legnago, Italy
- A.O.U.S. Luigi Gonzagauniversity Hospital
Orbassano, Torino, Italy
- Hospital Bellaria "carlo Alberto Pizzardi" - Operative Unit of Oncology
Bologna, Italy
- Irccs Azienda Ospedallera Universitaria San Martino-Ist-Istituto Nazionale Per la Ricerca Sul Cancro
Genova, Italy
- European Institute of Oncology (ieo) - Medical Care Unit
Milan, Italy
- S. Gerardo Hospital - Complex Structure of Medical Oncology
Monza, Italy
- Azienda Ospedaliera Universitaria Policlinico Della Seconda Universita Di Napoli
Naples, Italy
- University Hospital of Pisa, Department of Cardothoracic Surgery, Operative Unit of Pneumology
Pisa, Italy
- "santa Maria Degli Angeli" - Hospital - Complex Operative Unit of Oncology
Pordenone, Italy
- San Camillo-Forlanini Hospital - U.O.C. Pneumologia Oncologica 1
Rome, Italy
- Med-Polonia Sp. Z O.O.
Poznan, Poland
- L. Rydygier Provencial Hospitals in Torun, Dept. of Tumors Chemotherapy
Torun, Poland
- Maria Sklodowska-Curie Institute of Oncology in Warsaw
Warsaw, Poland
- Oncology Centre "sf. Nectarie"
Craiova, Dolj, Romania
- Pro. Dr. Alex Trestioreanu Institute of Oncology
Bucharest, Romania
- Prof. Dr. Ioan Chiricuta Institute of Oncology
Cluj-Napoca, Romania
- Republican Clinical Oncology Center Under the Ministry of Healthcare of Tatarstan Republic
Kazan', Tatarstan Republic, Russia
- Blokhin Russian Oncology Research Center
Moscow, Russia
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2014
- Primary completion
- 30 Apr 2016
- Completion
- 31 May 2016
- Last update posted
- 16 May 2025
- Registered enrollment
- 265
- Registry id
- NCT02093962
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.